NCT00201422View on ClinicalTrials.gov

Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 1996

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
MALT Lymphoma
Interventions
OTHER

Omeprazole, Amoxicillin, Clarithromycin

Omeprazole20 mg,Clarithromycin500 mg b.i.d.,Day 1-14 plus Amoxicillin 500 mg q.i.d.,Day 1-14 plus

Trial Locations (1)

112

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Health Research Institutes, Taiwan

OTHER

NCT00201422 - Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma | Biotech Hunter | Biotech Hunter